Consonance Capital Partners (Consonance), a leading US-based healthcare private equity firm, announced the closing of Consonance Private Equity III, L.P. (Fund III), with commitments totaling US$1.35 billion. After just under four months in the market, Consonance held its final close on Fund III at its hard cap in a heavily oversubscribed process. Consistent with its predecessor funds, Fund III will focus on investments in US healthcare companies in the lower and middle market.
Latham & Watkins LLP represented Consonance in the transaction with a team led by Investment Funds partners Andrea Schwartzman and Erin Bergey, with associate Ethan Cramer Gibbs. Advice was also provided on US tax matters by partner Greg Hannibal, with associate Nicholas Sun; and on funds regulatory matters by partners Laura Ferrell and Jennifer Tian.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
